1. Home
  2. BENF vs NBY Comparison

BENF vs NBY Comparison

Compare BENF & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BENF
  • NBY
  • Stock Information
  • Founded
  • BENF 2003
  • NBY 2000
  • Country
  • BENF United States
  • NBY United States
  • Employees
  • BENF N/A
  • NBY N/A
  • Industry
  • BENF Blank Checks
  • NBY
  • Sector
  • BENF Finance
  • NBY
  • Exchange
  • BENF Nasdaq
  • NBY Nasdaq
  • Market Cap
  • BENF 2.8M
  • NBY 3.4M
  • IPO Year
  • BENF N/A
  • NBY 2007
  • Fundamental
  • Price
  • BENF $0.28
  • NBY $0.60
  • Analyst Decision
  • BENF
  • NBY Strong Buy
  • Analyst Count
  • BENF 0
  • NBY 1
  • Target Price
  • BENF N/A
  • NBY $0.85
  • AVG Volume (30 Days)
  • BENF 2.6M
  • NBY 32.5K
  • Earning Date
  • BENF 08-13-2025
  • NBY 08-12-2025
  • Dividend Yield
  • BENF N/A
  • NBY N/A
  • EPS Growth
  • BENF N/A
  • NBY N/A
  • EPS
  • BENF N/A
  • NBY 0.57
  • Revenue
  • BENF N/A
  • NBY $9,781,000.00
  • Revenue This Year
  • BENF N/A
  • NBY $23.91
  • Revenue Next Year
  • BENF N/A
  • NBY $32.05
  • P/E Ratio
  • BENF N/A
  • NBY $1.25
  • Revenue Growth
  • BENF N/A
  • NBY 20.52
  • 52 Week Low
  • BENF $0.22
  • NBY $0.36
  • 52 Week High
  • BENF $6.27
  • NBY $2.47
  • Technical
  • Relative Strength Index (RSI)
  • BENF 42.56
  • NBY 52.90
  • Support Level
  • BENF $0.28
  • NBY $0.56
  • Resistance Level
  • BENF $0.31
  • NBY $0.64
  • Average True Range (ATR)
  • BENF 0.04
  • NBY 0.03
  • MACD
  • BENF -0.00
  • NBY 0.00
  • Stochastic Oscillator
  • BENF 7.20
  • NBY 50.20

About BENF Beneficient

Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: